This dataset, published on PDAPS.org, is cross-sectional and displays key features of state laws increasing access to buprenorphine and methadone during COVID-19 across all 50 states and the District of Columbia approved as of June 1, 2021.
This dataset, published on PDAPS.org, is cross-sectional and displays key features of mitigation laws at state correctional facilities relating to MOUD treatment across all 50 states and the District of Columbia in effect as of September 1, 2021.
This map presents state-level statutes and regulations that regulate earned sick leave laws in all 50 U.S. states and the District of Columbia, as of January 1, 2021. Specifically, the map identifies whether earned sick leave is regulated by state law, the probationary period an employer may impose before allowing an employee to use leave, the rate of accrual, the limit an employer may place on the use and accrual of leave, and under which circumstances leave may be used by an employee.
This legal map presents statutes and regulations that authorize the involuntary commitment of substance users, in effect as of March 1, 2018. It catalogs the statutory standards authorizing commitment, parties authorized to petition for a commitment, provisions surrounding clinical assessments, parameters of judicial review, time periods for commitment authorization, allowable treatment, and procedures for recommitment.
This map explores state laws and regulations that govern who can initiate the outpatient commitment process, the duration of commitment, whether the patient can refuse medication, what consequences exist for non-compliance, and whether outpatient commitment sets limits on the patient’s right to possess a firearm.